Ira Seth Winer

Wayne State University

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

University of Michigan

Research Subjects

Research Interests

Ira Seth Winer has a total of 194 co-authors. Here are the top co-authors by number of shared publications:

Joanne Xiu
Caris Life Sciences, Phoenix, Arizona, USA
45 shared publications
Nathaniel Jones
Mitchell Cancer Institute University of South Alabama, Mobile, AL, United States
41 shared publications
Anthony F. Shields
Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
40 shared publications
David Spetzler
Caris Life Sciences, Phoenix, USA
40 shared publications
Elisabeth I. Heath
Mayo Clinic Rochester Minnesota USA
40 shared publications
Frank Cameron Cackowski
Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, USA
40 shared publications

Latest Publications

Sort by

Website
Google Scholar
- 9 November 2026
- Published by Elsevier in International Journal of Gynecological Cancer
Rinatabart sesutecan (Rina-S®) in advanced ovarian cancer and advanced or recurrent endometrial cancer: Results from dose-optimization cohorts in the phase 1/2 RAINFOL™-01 study
by Elizabeth K. Lee, Oladapo Yeku, Justin Call, Debra L. Richardson, Noelle Cloven, Andrea Jewell, Leigh Seamon, Lyndsay J. Willmott, Gottfried E. Konecny, Douglas Orr, et al.
Website
Google Scholar
- 9 November 2026
- Published by Elsevier in International Journal of Gynecological Cancer
Rinatabart sesutecan (Rina-S®) in advanced ovarian cancer and advanced or recurrent endometrial cancer: Results from dose-optimization cohorts in the phase 1/2 RAINFOL™-01 study
by Elizabeth K. Lee, Oladapo Yeku, Justin Call, Debra L. Richardson, Noelle Cloven, Andrea Jewell, Leigh Seamon, Lyndsay J. Willmott, Gottfried E. Konecny, Douglas Orr, et al.
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Comparison of overall survival among chemotherapy-treated TP53-mutated and TP53-wild type patients in Caris CODEai clinico-genomic database
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S8 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Comparison of overall survival among chemotherapy-treated TP53-mutated and TP53-wild type patients in Caris CODEai clinico-genomic database
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
COXPH model for patients with stage information
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S3 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
COXPH model for patients with stage information
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Copy number alterations (CNAs) and fusions among cohort
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Copy number alterations (CNAs) and fusions among cohort
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Fiugre S4 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Overall survival by RUCA code and poverty
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Fiugre S4 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Overall survival by RUCA code and poverty
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
COXPH model for patients with at least 6-mo overall survival
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
COXPH model for patients with at least 6-mo overall survival
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Comparison of Caris cohort data with Puckrein dataset
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Comparison of Caris cohort data with Puckrein dataset
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Gene mutations according to poverty level and RUCA codes
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S7 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Gene mutations according to poverty level and RUCA codes
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Overall survival of cohort by stage
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Overall survival of cohort by stage
Open Access
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Prevalence of common mutations in tumor subtypes
Website
Google Scholar
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
by Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, et al.
Prevalence of common mutations in tumor subtypes

Show all